Skip to main content
Erschienen in: Supportive Care in Cancer 1/2019

26.06.2018 | Original Article

Nausea in advanced cancer: relationships between intensity, burden, and the need for help

verfasst von: Signe Ladegaard Harder, Mogens Groenvold, Jørn Herrstedt, Anna Thit Johnsen

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed at expanding the knowledge of nausea in patients with advanced cancer by elucidating (a) the prevalences of patients having nausea, experiencing nausea as a problem, and having a need for help with their nausea, respectively, (b) determining variables associated with nausea, and (c) investigating the relation between nausea and the need for help regarding nausea.

Methods

In 2004–2006, the EORTC QLQ-C30 and the Three-Levels-of-Needs Questionnaire (3LNQ) were mailed to 2364 patients with advanced cancer who had been in contact with one of the 54 hospital departments within the past year. Further information was collected from medical records.

Results

Patient-response rate was 61%. Twenty-two percent reported having had some degree of nausea within the past week, with a mean nausea score of 10.4 and a two-item combined nausea and vomiting score of 7.5 (0–100, 100 = “very much”). Factors associated with nausea on the multivariate level were contact type (inpatient/outpatient) and treatment status (receiving ongoing oncologic treatment yes/no).
“Nausea intensity” and “nausea problem burden” showed acceptable abilities to distinguish between patients having or not having an unmet need for help regarding nausea with areas under the curve (AUCs) of 0.81 and 0.82, respectively.

Conclusions

Around one in four patients with advanced cancer reported nausea within the past week, highest in patients who were inpatients or undergoing active oncologic treatment. Almost all patients reporting nausea on the EORTC QLQ-C30 experienced this to be a problem, and the 3LNQ can therefore be restricted to cases where additional details are needed.
Literatur
8.
Zurück zum Zitat American Joint Committee on Cancer (2002) AJCC cancer staging manual. In: Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (ed). Springer, New York American Joint Committee on Cancer (2002) AJCC cancer staging manual. In: Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (ed). Springer, New York
9.
Zurück zum Zitat Johnsen AT, Petersen MA, Pedersen L, Houmann LJ, Groenvold M (2013) Do advanced cancer patients in Denmark receive the help they need? A nationally representative survey of the need related to 12 frequent symptoms/problems. Psychooncology 22(8):1724–1730. https://doi.org/10.1002/pon.3204 CrossRefPubMed Johnsen AT, Petersen MA, Pedersen L, Houmann LJ, Groenvold M (2013) Do advanced cancer patients in Denmark receive the help they need? A nationally representative survey of the need related to 12 frequent symptoms/problems. Psychooncology 22(8):1724–1730. https://​doi.​org/​10.​1002/​pon.​3204 CrossRefPubMed
12.
Zurück zum Zitat AN FPM, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 Scoring Manual, 3rd edn. European Organisation for Research and Treatment of Cancer, Brussels AN FPM, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 Scoring Manual, 3rd edn. European Organisation for Research and Treatment of Cancer, Brussels
13.
Zurück zum Zitat Looney SW, Hagan JL (2015) Analysis of biomarker data. John Wiley & Sons, Incorporated, Somerset Looney SW, Hagan JL (2015) Analysis of biomarker data. John Wiley & Sons, Incorporated, Somerset
18.
Zurück zum Zitat Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L et al (1994) The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30a(9):1326–1336CrossRefPubMed Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L et al (1994) The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30a(9):1326–1336CrossRefPubMed
20.
Zurück zum Zitat Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T (1991) Symptom control during the last week of life on a palliative care unit. J Palliat Care 7(1):5–11PubMed Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T (1991) Symptom control during the last week of life on a palliative care unit. J Palliat Care 7(1):5–11PubMed
21.
Zurück zum Zitat Conill C, Verger E, Henriquez I, Saiz N, Espier M, Lugo F, Garrigos A (1997) Symptom prevalence in the last week of life. J Pain Symptom Manag 14(6):328–331CrossRef Conill C, Verger E, Henriquez I, Saiz N, Espier M, Lugo F, Garrigos A (1997) Symptom prevalence in the last week of life. J Pain Symptom Manag 14(6):328–331CrossRef
22.
24.
Zurück zum Zitat Vainio A, Auvinen A (1996) Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Symptom Manage 12(1):3–10CrossRefPubMed Vainio A, Auvinen A (1996) Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Symptom Manage 12(1):3–10CrossRefPubMed
25.
27.
Zurück zum Zitat Raman S, Ding K, Chow E, Meyer RM, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JSY, Nabid A, Haas R, Wiggenraad R, Babington S, Demas WF, Wilson CF, Wong RKS, Zhu L, Brundage M (2017) Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases. Qual Life Res 27:1089–1098. https://doi.org/10.1007/s11136-017-1745-8 CrossRefPubMed Raman S, Ding K, Chow E, Meyer RM, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JSY, Nabid A, Haas R, Wiggenraad R, Babington S, Demas WF, Wilson CF, Wong RKS, Zhu L, Brundage M (2017) Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases. Qual Life Res 27:1089–1098. https://​doi.​org/​10.​1007/​s11136-017-1745-8 CrossRefPubMed
29.
Zurück zum Zitat Groenvold M, Petersen MA, Damkier A, Neergaard MA, Nielsen JB, Pedersen L, Sjogren P, Stromgren AS, Vejlgaard TB, Gluud C, Lindschou J, Fayers P, Higginson IJ, Johnsen AT (2017) Randomised clinical trial of early specialist palliative care plus standard care versus standard care alone in patients with advanced cancer: the Danish palliative care trial. Palliat Med 269216317705100:814–824. https://doi.org/10.1177/0269216317705100 CrossRef Groenvold M, Petersen MA, Damkier A, Neergaard MA, Nielsen JB, Pedersen L, Sjogren P, Stromgren AS, Vejlgaard TB, Gluud C, Lindschou J, Fayers P, Higginson IJ, Johnsen AT (2017) Randomised clinical trial of early specialist palliative care plus standard care versus standard care alone in patients with advanced cancer: the Danish palliative care trial. Palliat Med 269216317705100:814–824. https://​doi.​org/​10.​1177/​0269216317705100​ CrossRef
31.
Zurück zum Zitat Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8(3):175–179CrossRefPubMed Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8(3):175–179CrossRefPubMed
Metadaten
Titel
Nausea in advanced cancer: relationships between intensity, burden, and the need for help
verfasst von
Signe Ladegaard Harder
Mogens Groenvold
Jørn Herrstedt
Anna Thit Johnsen
Publikationsdatum
26.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4326-7

Weitere Artikel der Ausgabe 1/2019

Supportive Care in Cancer 1/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.